Determination of 5-S-cysteinyldopa in plasma and urine using a fully automated solid-phase extraction-high-performance liquid chromatographic method for an improvement of specificity and sensitivity of this prognostic marker of malignant melanoma

Journal of Chromatography B: Biomedical Sciences and Applications

Volumn 727, Issue 1-2, 1999, Pages 31-42

  Hartleb, Jürgen ^a   Damm, York ^b   Arndt, Rüdiger ^a   Christophers, Enno ^b   Stockfleth, Eggert ^b  

^a Arndt and Partner   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

5 S cysteinyldopa; Metastatic melanoma; Plasma; Urine

Indexed keywords

CYSTEINYLDOPA; TUMOR MARKER;

ARTICLE; AUTOANALYSIS; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MELANOMA; METASTASIS; METHODOLOGY; PLASMA; PRIORITY JOURNAL; PROGNOSIS; SOLID PHASE EXTRACTION; URINALYSIS;

AUTOMATION; CALIBRATION; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINYLDOPA; HUMANS; MELANOMA; PROGNOSIS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032898429     PISSN: 13872273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(99)00098-5     Document Type: Article

References (25)

1. Reglin F. Praxis-Telegramm. 2:1996;22.
2. Ito S. J. Dermatol. 19:1992;802.
3. Ito S., Homma K., Kiyota M., Fujita K., Jimbow K. J. Invest. Dermatol. 80:1983;207.
4. Westerhof W., Pavel S., Kammeyer A., Beusenberg F.D., Cormane R. J. Invest. Dermatol. 89:1987;78.
5. Rorsman H., Rosengren A.-M., Rosengren E. Acta Dermatovener (Stockholm). 53:1973;248.
6. Agrup G., Agrup P., Andersson T., Hafström L., Hansson C., Jacobsson S., Jönsson P.E., Rorsman H., Rosengren A.-M., Rosengren E. Acta Derm. Venereol. 59:1979;381.
7. Agrup G., Agrup P., Andersson T., Falck B., Hansson J.-A., Jacobsson S., Rorsman H., Rosengren E., Rosengren A.-M. Acta Dermatovener (Stockholm). 57:1977;113.
8. Hansson C., Edholm L.-E., Agrup G., Rorsman H., Rosengren A.-M., Rosengren E. Clin. Chim. Acta. 88:1979;419.
9. Hara H., Chino K., Kawanami T., Sameshima T., Morishima T. J. Dermatol. 19:1992;806.
10. Yamada K., Walsh N., Hara H., Jimbow K., Chen H., Ito S. Arch. Dermatol. 128:1992;491.
11. Horikoshi T., Ito S., Wakamatsu K., Onodera H., Eguchi H. Cancer. 73:1994;629.
12. Wakamatsu K., Ito S., Horikoshi T. Melanoma Res. 1:1991;141.
13. Horikoshi T., Ito S. J. Dermatol. 19:1992;809.
14. Hansson C., Edholm L.-E., Agrup G., Rorsman H., Rosengren A.-M., Rosengren E. Clin. Chim. Acta. 88:1978;419.
15. Kagedal B., Pettersson A. Clin. Chem. 29:1983;2031.
16. Ito S., Kato T., Maruta K., Fujita K. J. Chromatogr. 311:1984;154.
17. Nimmo J.E., Gawkrodger D.J., O'Docherty C.St.J., Going S.M., Percy-Robb I.W., Hunter J.A.A. Br. J. Dermatol. 118:1988;487.
18. Peterson L.L., Woodward W.R., Fletcher W.S., Palmquist M., Tucker M.A., Ilias A. J. Am. Acad. Dermatol. 19:1988;509.
19. Hara H., Walsh N., Yamada K., Jimbow K. J. Invest. Dermatol. 102:1994;501.
20. Scheibl Ch., Kohl B., Fiehn W. Klin. Lab. 39:1993;377.
21. Hansson C., Agrup G., Rorsman H., Rosengren A.-M., Rosengren E., Edholm L.-E. J. Chromatogr. 162:1979;7.
22. Kagedal B., Pettersson A. Determination of 5-S-cysteinyldopa in serum by high-performance liquid chromatography after prepurification with immobilized boric acid. Bagnara J., Klaus S.N., Paul E., Schartl M. Pigment cell 1985, biological, molecular and clinical aspects of pigmentation. 1985;721 University of Tokyo Press, Tokyo.
23. Wakamatsu K., Ito S. Clin. Chem. 40:1994;495.
24. Huang T., Wall J., Kabra P. J. Chromatogr. 452:1988;409.
25. Kagedal B., Lenner L., Arstrand K., Hansson C. Pigm. Cell Res. Suppl. 2:1992;304.